Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 20 Carcinoma, Renal Cell 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Endometrial Neoplasms 7 Neoplasms 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Neuroendocrine Tumors 3 Melanoma 3 Liver Neoplasms 3 Vulvar Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Thyroid Carcinoma, Anaplastic 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Penile Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lung Neoplasms 1 Kidney Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

GIST × lenvatinib × 90 days × Clear all

NCT07096609 2026-04-03

LONGIST

Asan Medical Center

Phase 1/2 Recruiting

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡